Kelland LR - Search Results

1

Mechanism of action of an orally administered platinum complex [ammine bis butyrato cyclohexylamine dichloroplatinum (IV) (JM221)] in intrinsically cisplatin-resistant human ovarian carcinoma in vitro.

McKeage MJ, Abel G, Kelland LR, Harrap KR. McKeage MJ, et al. Among authors: kelland lr. Br J Cancer. 1994 Jan;69(1):1-7. doi: 10.1038/bjc.1994.1. Br J Cancer. 1994. PMID: 8286188 Free PMC article.

2

Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.

Kelland LR, Mistry P, Abel G, Freidlos F, Loh SY, Roberts JJ, Harrap KR. Kelland LR, et al. Cancer Res. 1992 Apr 1;52(7):1710-6. Cancer Res. 1992. PMID: 1312897

3

Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.

Kelland LR, Abel G. Kelland LR, et al. Cancer Chemother Pharmacol. 1992;30(6):444-50. doi: 10.1007/BF00685595. Cancer Chemother Pharmacol. 1992. PMID: 1356649

4

Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.

Mistry P, Kelland LR, Loh SY, Abel G, Murrer BA, Harrap KR. Mistry P, et al. Among authors: kelland lr. Cancer Res. 1992 Nov 15;52(22):6188-93. Cancer Res. 1992. PMID: 1423261

5

Reduced drug accumulation as a major mechanism of acquired resistance to cisplatin in a human ovarian carcinoma cell line: circumvention studies using novel platinum (II) and (IV) ammine/amine complexes.

Loh SY, Mistry P, Kelland LR, Abel G, Harrap KR. Loh SY, et al. Among authors: kelland lr. Br J Cancer. 1992 Dec;66(6):1109-15. doi: 10.1038/bjc.1992.419. Br J Cancer. 1992. PMID: 1457352 Free PMC article.

6

Human ovarian-carcinoma cell lines and companion xenografts: a disease-oriented approach to new platinum anticancer drug discovery.

Kelland LR, Jones M, Abel G, Valenti M, Gwynne J, Harrap KR. Kelland LR, et al. Cancer Chemother Pharmacol. 1992;30(1):43-50. doi: 10.1007/BF00686484. Cancer Chemother Pharmacol. 1992. PMID: 1586979

7

Kelland LR, Mistry P, Abel G, Loh SY, O'Neill CF, Murrer BA, Harrap KR. Kelland LR, et al. Cancer Res. 1992 Jul 15;52(14):3857-64. Cancer Res. 1992. PMID: 1617660

8

Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.

Kelland LR, Murrer BA, Abel G, Giandomenico CM, Mistry P, Harrap KR. Kelland LR, et al. Cancer Res. 1992 Feb 15;52(4):822-8. Cancer Res. 1992. PMID: 1737343

9

Platinum coordination complexes which circumvent cisplatin resistance.

Harrap KR, Kelland LR, Jones M, Goddard PM, Orr RM, Morgan SE, Murrer BA, Abrams MJ, Giandomenico CM, Cobbleigh T. Harrap KR, et al. Among authors: kelland lr. Adv Enzyme Regul. 1991;31:31-43. doi: 10.1016/0065-2571(91)90007-9. Adv Enzyme Regul. 1991. PMID: 1877393

10

The relationships between glutathione, glutathione-S-transferase and cytotoxicity of platinum drugs and melphalan in eight human ovarian carcinoma cell lines.

Mistry P, Kelland LR, Abel G, Sidhar S, Harrap KR. Mistry P, et al. Among authors: kelland lr. Br J Cancer. 1991 Aug;64(2):215-20. doi: 10.1038/bjc.1991.279. Br J Cancer. 1991. PMID: 1892748 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters